VR Logo

Cytosorbents Corporation (CTSO) download report


Healthcare | Medical Devices & Equipment

Cytosorbents Corporation (CTSO) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology.

IPO Date: 07-Nov-2013

CEO & Director: Dr. Phillip P. Chan M.D., Ph.D.

Pres & COO: Mr. Vincent J. Capponi M.S., MS

Listing: NASDAQ: CTSO

Country: United States

Headquarters: Princeton, NJ

Website: https://www.cytosorbents.com

Key Facts

Market cap: $87.56 Mln

Revenue (TTM): $18.71 Mln

Earnings (TTM): $-29.36 Mln

Cash: $43.02 Mln

Total Debt: $13.66 Mln

Insider's Holding: 8.99%

Liquidity: Low

52 Week range: $1.70 - 9.80

Shares outstanding: 43,562,100

10 Years Aggregate:

  • CFO: $-83.18 Mln
  • EBITDA: $-113.86 Mln
  • Net Profit: $-115.07 Mln

Stock Performance

Time Period Cytosorbents (CTSO) S&P BSE Sensex S&P Small-Cap 600
YTD-52.03-9.18-18.78
1 month-1.95-4.78-8.00
3 months-36.99-9.66-13.65
1 Year-73.380.81-17.19
3 Years-32.7510.336.10
5 Years-14.1111.345.87
10 Years-4.5411.749.84
As on 01-Jul-2022
Year Cytosorbents (CTSO) S&P Small-Cap 600 S&P BSE Sensex
2021-47.4325.2721.99
2020107.019.5715.75
2019-52.3520.8614.38
201824.16-9.705.87
201719.2711.7327.91
2016-2.1524.741.95
2015-44.02-3.36-5.03